Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40005335
Localisation
Germany
Europe
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
08/02/2024
Statut
Classification
1.5°C
Année cible
2030
BioNTech commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2021 base year. BioNTech commits that 72% of its suppliers by emissions covering purchased goods and services, capital goods and upstream transportation and distribution, will have science based targets by 2027.
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
US09075V1026
LEI
894500UZJ5LG1F8J1U58
Source : Science Based Targets initiative | Données publiques